Taylor Business Institute

Latest Taylor Business Institute News

CHICAGO, Oct. 17, 2005— Abelson-Taylor, an independent Chicago agency known for its award-winning creative work, has promoted Molly McNally to account supervisor. McNally, who was previously senior account executive, will supervise the agency’s direct to consumer (DTC) business for two oncology products and will report to Richard Blocki, Director, DTC. A marketing professional with 13 years of experience on both the client and agency sides, McNally has been with Abelson-Taylor since 2003, handling marketing and development initiatives for Sanofi-Synthelabo’s sleep medication Ambien (zolpidem tartrate), and Amgen’s Aranesp (darbepoetin alfa), a treatment for chemotherapy-induced anemia and Kepivance (palifermin) for the treatment of oral mucositis.“Molly’s strong professional and consumer marketing experience, as well as her prior work with Amgen, will ensure a smooth transition in her new role with the account,” said Blocki, adding that her experience in both the domestic and global arenas will be a major asset as the agency continues to expand its DTC business.Prior to joining Abelson-Taylor, McNally spent five years—most recently as senior account executive—at Coil Counts Ford & Cheney, a consumer agency in Chicago, where she handled several hospital and health care accounts. She also held positions as marketing manager for the Chicago Institute of Neurosurgery - more available